Pöyry awarded contract for detail engineering at UPM Biorefinery project in Lappeenranta, Finland; services will be carried out 2012-2014
Allison Oesterle
Apr 26, 2012 – Pöyry PLC
VANTAA, Finland
,
April 26, 2012
(press release)
– Pöyry's Industry business group has been awarded an engineering contract for detail engineering in the UPM Biorefinery project in Lappeenranta, Finland. The order has been booked in the second quarter order book. The parties have agreed not to disclose the value of the assignment.
Pöyry's engineering assignment includes services for civil and plant engineering, project control, procurement, document management, and industrial safety. The services will be carried out during 2012-2014.
The Lappeenranta Biorefinery is UPM's first step in its strategy towards being a key player in advanced biofuels production and therefore a vital part of UPM's Biofore strategy.
This assignment strengthens Pöyry's strategic position as a provider of engineering and project services to the Biofuels and Oil Refining industries.
PÖYRY PLC
Additional information:
Tuukka Sormunen, President, Business Area Chemicals
tel. +358 10 33 22128
Martin Kuzaj, Executive Vice President, Industry Business Group
tel. + 358 10 33 21179
Pöyry is a global consulting and engineering company dedicated to balanced sustainability and responsible business. With quality and integrity at our core, we deliver best-in-class management consulting, total solutions, and design and supervision. Our in-depth expertise extends to the fields of energy, industry, transportation, water, environment and real estate. Pöyry has about 7,000 experts and a local office network in about 50 countries. Pöyry's net sales in 2011 were EUR 796 million and the company's shares are quoted on NASDAQ OMX Helsinki (Pöyry PLC: POY1V).
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.